Published in Contrast Media Mol Imaging on April 04, 2014
Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier. Int J Nanomedicine (2016) 0.76
Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol (2005) 5.60
Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res (1998) 3.30
Role of oxidants in ischemic brain damage. Stroke (1996) 3.10
Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn Reson Med (1997) 2.93
Fluorescence depolarization studies of phase transitions and fluidity in phospholipid bilayers. 2 Two-component phosphatidylcholine liposomes. Biochemistry (1976) 2.63
Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci (1998) 2.39
In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn Reson Med (1998) 2.36
A newly identified role for superoxide in inflammatory pain. J Pharmacol Exp Ther (2004) 2.21
Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res (2004) 2.10
Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. Acc Chem Res (2009) 1.86
In vivo detection of neuroarchitecture in the rodent brain using manganese-enhanced MRI. Neuroimage (2004) 1.85
Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci (1997) 1.84
Requirement for superoxide in excitotoxic cell death. Neuron (1996) 1.80
Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain. Exp Neurol (2005) 1.78
Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury. J Pharmacol Exp Ther (1998) 1.73
Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery. J Neurooncol (2004) 1.61
Manganese-enhanced magnetic resonance imaging (MEMRI). NMR Biomed (2004) 1.59
Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Mol Neurobiol (2010) 1.51
Manganese superoxide dismutase, MnSOD and its mimics. Biochim Biophys Acta (2011) 1.46
Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension (1999) 1.44
Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant. J Neurosci (2001) 1.38
Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route. Pharm Res (2005) 1.19
Tamoxifen neuroprotection in cerebral ischemia involves attenuation of kinase activation and superoxide production and potentiation of mitochondrial superoxide dismutase. Endocrinology (2007) 1.17
Oxygen radicals in focal cerebral ischemia. Brain Pathol (1994) 1.16
A p(O(2))-Responsive MRI Contrast Agent Based on the Redox Switch of Manganese(II / III) - Porphyrin Complexes. Angew Chem Int Ed Engl (2000) 1.15
Correlation of relaxivity with coordination number in six-, seven-, and eight-coordinate Mn(II) complexes of pendant-arm cyclen derivatives. Inorg Chem (2009) 1.14
Computer-aided design (CAD) of Mn(II) complexes: superoxide dismutase mimetics with catalytic activity exceeding the native enzyme. Inorg Chem (2001) 1.10
Permeability of bilayer lipid membranes for superoxide (O2-.) radicals. Biochim Biophys Acta (1984) 1.06
Neuroprotective efficacy from a lipophilic redox-modulating Mn(III) N-Hexylpyridylporphyrin, MnTnHex-2-PyP: rodent models of ischemic stroke and subarachnoid hemorrhage. J Pharmacol Exp Ther (2011) 1.01
Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J Cardiovasc Pharmacol (1994) 1.00
Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion. Br J Pharmacol (2001) 0.98
Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. Stroke (1990) 0.98
Electron spin resonance study on the permeability of superoxide radicals in lipid bilayers and biological membranes. FEBS Lett (1992) 0.96
Prevention of kainic acid-induced changes in nitric oxide level and neuronal cell damage in the rat hippocampus by manganese complexes of curcumin and diacetylcurcumin. Life Sci (2005) 0.95
Cardiovascular toxicity and tissue proton T1 response to manganese injection in the dog and rabbit. AJR Am J Roentgenol (1983) 0.95
Liposomes as MR contrast agents: pros and cons. Magn Reson Med (1991) 0.93
Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells. Biomaterials (2012) 0.93
Serial MRI study of the enhanced therapeutic effects of liposome-encapsulated citicoline in cerebral ischemia. Int J Pharm (2010) 0.91
Augmentation of nitric oxide, superoxide, and peroxynitrite production during cerebral ischemia and reperfusion in the rat. Neurochem Res (1998) 0.91
Thermosensitive paramagnetic liposomes for temperature control during MR imaging-guided hyperthermia: in vitro feasibility studies. Acad Radiol (2000) 0.90
Manganese-based liposomes. Comparative approaches. Invest Radiol (1993) 0.89
Protective effect of a new nonpeptidyl mimetic of SOD, M40401, against focal cerebral ischemia in the rat. Brain Res (2003) 0.88
The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats. J Control Release (2007) 0.87
Effects of naloxone on lactate, pyruvate metabolism and antioxidant enzyme activity in rat cerebral ischemia/reperfusion. Neurosci Lett (2000) 0.86
A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents. Invest Radiol (1990) 0.84
Improved nuclear magnetic resonance microscopic visualization of joint cartilage using liposome entrapped contrast agents. Invest Radiol (1998) 0.83
Boronated metalloporphyrins: a novel approach to the diagnosis and treatment of cancer using contrast-enhanced MR imaging and neutron capture therapy. J Magn Reson Imaging (1993) 0.81
Contrast agents for cerebral perfusion MR imaging. J Magn Reson Imaging (1994) 0.80
Liposome-encapsulated hemoglobin ameliorates ischemic stroke in nonhuman primates: an acute study. J Pharmacol Exp Ther (2009) 0.80
Therapeutic potentials of an artificial oxygen-carrier, liposome-encapsulated hemoglobin, for ischemia/reperfusion-induced cerebral dysfunction in rats. J Pharmacol Sci (2010) 0.79
Liposome encapsulated MnCl2 as a liver specific contrast agent for magnetic resonance imaging. Invest Radiol (1990) 0.79
Status of liposomes as MR contrast agents. J Magn Reson Imaging (1993) 0.78
Gene transfer of Cu/Zn SOD to cerebral vessels prevents FPI-induced CBF autoregulatory dysfunction. Am J Physiol Heart Circ Physiol (2002) 0.78
Spectroscopic and metabolic effects of MnCl2 and MnDPDP on the isolated and perfused rat heart. Invest Radiol (1997) 0.78
Dose dependence and temporal evolution of the T1 relaxation time and MRI contrast in the rat brain after subcutaneous injection of manganese chloride. Magn Reson Med (2012) 0.78
Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in rats: effect of oxygen affinity. Artif Organs (2009) 0.77
Biopharmaceutics of boronated radiosensitizers: liposomal formulation of MnBOPP (manganese chelate of 2,4-(alpha, beta-dihydroxyethyl) deuterioporphyrin IX) and comparative toxicity in mice. J Pharm Sci (1999) 0.76
Liposomes bearing membrane-bound complexes of manganese as magnetic resonance contrast agents. Invest Radiol (1994) 0.76
Neuroprotection by intrathecal application of liposome-entrapped fasudil in a rat model of ischemia. Neurol Med Chir (Tokyo) (2001) 0.76
Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc Natl Acad Sci U S A (2004) 2.77
Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. Radiology (2006) 1.79
Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res (2003) 1.55
A novel silicon patch-clamp chip permits high-fidelity recording of ion channel activity from functionally defined neurons. Biotechnol Bioeng (2010) 1.49
Characterizing vascular parameters in hypoxic regions: a combined magnetic resonance and optical imaging study of a human prostate cancer model. Cancer Res (2006) 1.41
DTPA-bisamide-based MR sensor agents for peroxidase imaging. Org Lett (2005) 1.35
Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. Bioconjug Chem (2002) 1.29
Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques. Circulation (2009) 1.26
Noninvasive magnetic resonance imaging of microvascular changes in type 1 diabetes. Diabetes (2007) 1.18
Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. Neoplasia (2003) 1.18
Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. Mol Imaging (2003) 1.18
Human myeloperoxidase: a potential target for molecular MR imaging in atherosclerosis. Magn Reson Med (2004) 1.16
Amplification strategies in MR imaging: activation and accumulation of sensing contrast agents (SCAs). J Magn Reson Imaging (2006) 1.07
Imaging molecular expression on vascular endothelial cells by in vivo immunofluorescence microscopy. Mol Imaging (2006) 1.02
A novel thymidine phosphoramidite synthon for incorporation of internucleoside phosphate linkers during automated oligodeoxynucleotide synthesis. Nucleosides Nucleotides Nucleic Acids (2008) 0.98
Fluorescence resonance energy transfer in near-infrared fluorescent oligonucleotide probes for detecting protein-DNA interactions. Proc Natl Acad Sci U S A (2008) 0.97
Near-infrared fluorescent oligodeoxyribonucleotide reporters for sensing NF-kappaB DNA interactions in vitro. Oligonucleotides (2008) 0.92
Synthesis and properties of fluorescent NF-kappa B-recognizing hairpin oligodeoxyribonucleotide decoys. Bioconjug Chem (2004) 0.92
Imaging of VEGF receptor kinase inhibitor-induced antiangiogenic effects in drug-resistant human adenocarcinoma model. Neoplasia (2005) 0.88
In vivo fluorescence lifetime detection of an activatable probe in infarcted myocardium. J Biomed Opt (2012) 0.86
Linear polyethyleneimine grafted to a hyperbranched poly(ethylene glycol)-like core: a copolymer for gene delivery. Bioconjug Chem (2006) 0.86
Steady-state and dynamic contrast MR imaging of human prostate cancer xenograft tumors: a comparative study. Technol Cancer Res Treat (2002) 0.85
Targeted signal-amplifying enzymes enhance MRI of EGFR expression in an orthotopic model of human glioma. Cancer Res (2011) 0.85
In vitro and In vivo imaging of antivasculogenesis induced by Noggin protein expression in human venous endothelial cells. FASEB J (2009) 0.85
Imaging the pancreatic vasculature in diabetes models. Diabetes Metab Res Rev (2011) 0.82
Methotrexate-induced accumulation of fluorescent annexin V in collagen-induced arthritis. Mol Imaging (2005) 0.82
A paramagnetic contrast agent for detecting tyrosinase activity. Chembiochem (2007) 0.81
Protected graft copolymer (PGC) basal formulation of insulin as potentially safer alternative to Lantus® (insulin-glargine): a streptozotocin-induced, diabetic Sprague Dawley rats study. Pharm Res (2011) 0.81
Hairpin-like fluorescent probe for imaging of NF-κB transcription factor activity. Bioconjug Chem (2011) 0.81
Environment-sensitive and enzyme-sensitive MR contrast agents. Handb Exp Pharmacol (2008) 0.81
Cell death in NF-kappaB-dependent tumour cell lines as a result of NF-kappaB trapping by linker-modified hairpin decoy oligonucleotide. FEBS Lett (2007) 0.80
Novel hyperbranched dendron for gene transfer in vitro and in vivo. Bioconjug Chem (2004) 0.79
Plate capture assay of fluorescent oligonucleotide duplex reporter-transcription factor complexes. Bioconjug Chem (2009) 0.79
Engineering of technetium-99m-binding artificial receptors for imaging gene expression. J Gene Med (2003) 0.76
Orthotopic expression of noggin protein in cancer cells inhibits human lung carcinoma growth in vivo. Mol Imaging Biol (2012) 0.75
The three-dimensional context of a double helix determines the fluorescence of the internucleoside-tethered pair of fluorophores. Mol Biosyst (2013) 0.75
MR signal amplification for imaging of the mutant EGF receptor in orthotopic human glioma model. Mol Imaging Biol (2013) 0.75